Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,414 public trials 350 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial

NCT00649792

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • HOPE Research Institute Phoenix, Arizona, United States
  • Neurological Associates Fayetteville, Arkansas, United States
  • Alta Bates Summit Medical Center - Research and Education Institute Berkeley, California, United States
View all 42 locations
View Trial Details
Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

NCT00648908

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • USC, Keck School of Medicine Health Care Consultation Center Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Shepherd Center Atlanta, Georgia, United States
View all 32 locations
View Trial Details
Completed

Duloxetine for Multiple Sclerosis Pain

NCT00755807

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States
View all 22 locations
View Trial Details
Completed

Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)

NCT00395200

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +8 more
Locations
  • University of Cambridge Dept of Clinical Neurosciences Cambridge, Cambridgeshire, United Kingdom
  • University College London Institute of Neurology London, United Kingdom
View Trial Details

Related conditions